MedPharm, a provider in topical and transdermal drug delivery, has moved into its newly expanded facility in Durham, NC.
 
The $4 million expansion has tripled the facility’s footprint to approximately 25,000 sq.-ft, significantly expanding capacity to serve the topical and transdermal market. 
 
The company has also added topical and transdermal services covering pre-formulation and formulation development, in vitro release, in vitro penetration/permeation, tissue culture, analytical/bioanalysis, custom device development and tissue engineering. The new space will also include dedicated innovation, microbiology and histology labs.  
 
“We are excited to be able to offer an expanded and unmatched level of services from our facility in the North Carolina Research Triangle Park area,” said Eugene Ciolfi MedPharm’s president and chief executive officer.  “The expanded space has a streamlined workflow that segregates phases of work and makes transition through each project more efficient with complimentary equipment positioned where it’s most needed.”
 
The new lab expands capacity for MedPharm’s models which aim to de-risk its customers’ development programs as it accommodates automated and high throughput analytical instrumentation to help improve turnaround times and elevate the consistent quality of data.
 
The expansion will create more than 100 new highly skilled scientific and strategic positions in Research Triangle Park in NC.